Crossref
Temsirolimus: Safety and Efficacy in the Treatment of Renal Cell Carcinoma
Clinical Medicine Reviews in Oncology · 2011
DOI: 10.4137/cmro.s1632 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Medicine Reviews in Oncology, 2011. Verfasst von M. Hammad Ather and Syed M. Nazim.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Nazim, M. H. A. A. S. M. (2011). Temsirolimus: Safety and Efficacy in the Treatment of Renal Cell Carcinoma. Clinical Medicine Reviews in Oncology. https://doi.org/10.4137/cmro.s1632
Vancouver
Nazim MHAASM. Temsirolimus: Safety and Efficacy in the Treatment of Renal Cell Carcinoma. Clinical Medicine Reviews in Oncology. 2011. doi:10.4137/cmro.s1632
BibTeX
@article{Nazim2011,
author = {Nazim, M. Hammad Ather and Syed M.},
title = {Temsirolimus: Safety and Efficacy in the Treatment of Renal Cell Carcinoma},
journal = {Clinical Medicine Reviews in Oncology},
year = {2011},
doi = {10.4137/cmro.s1632}
}
EUVIMED